[Pharmacodynamics and studies on the mechanism of action of HB 419].
D000818:Animals; D000900:Anti-Bacterial Agents; D001786:Blood Glucose / Q000032:analysis*; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000097:blood; D004285:Dogs; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005944:Glucosamine / Q000037:antagonists & inhibitors; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced; D007003:Hypoglycemia / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D051379:Mice; D009005:Monosaccharides / Q000037:antagonists & inhibitors; D010179:Pancreas / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D013045:Species Specificity; D013268:Stimulation, Chemical; D013997:Time Factors; D014508:Urea / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007004:Hypoglycemic Agents; D007328:Insulin; D008112:Liver Glycogen; D009005:Monosaccharides; D014508:Urea; D005944:Glucosamine
Pharmakodynamik und Untersuchungen zum Wirkungsmechanismus von HB 419.